Trxade Group (MEDS)
NASDAQ:MEDS
Holding MEDS?
Track your performance easily

Trxade Group (MEDS) Financial Statements

150 Followers

Trxade Group Financial Overview

Trxade Group's market cap is currently ―. The company's EPS TTM is $-26.961; its P/E ratio is -0.28; Trxade Group is scheduled to report earnings on July 22, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 18.70K-$ 1.72M$ 2.06M$ 2.25M
Gross Profit$ -703.00-$ -2.31M$ 1.70M$ 1.64M
EBIT$ -1.37M$ -5.75M$ -9.96M$ 901.39K$ -911.39K
EBITDA$ -1.36M$ -5.75M$ -9.25M$ 1.13M-
Net Income Common Stockholders$ -1.83M$ 22.03M$ -11.67M$ -3.53M$ -1.09M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 7.72M$ 3.50M$ 151.91K$ 34.03K$ 745.56K
Total Assets$ 14.85M$ 16.74M$ 12.53M$ 21.65M$ 3.74M
Total Debt$ 193.60K$ 201.58K$ 7.10M$ 6.48M$ 211.43K
Net Debt$ -7.53M$ -3.30M$ 6.95M$ 6.45M$ -534.13K
Total Liabilities$ 3.06M$ 3.12M$ 11.99M$ 10.09M$ 5.04M
Stockholders Equity$ 11.79M$ 13.62M$ 542.35K$ 11.56M$ -1.29M
Cash Flow-
Free Cash Flow$ 4.22M$ -10.19M$ -386.35K$ -603.11K-
Operating Cash Flow$ 4.22M$ -10.19M$ -386.35K$ -603.11K$ 328.57K
Investing Cash Flow$ -774.00$ 27.43M$ -418.74K$ -207.11K$ -51.80K
Financing Cash Flow-$ -13.90M$ 1.84M$ 114.96K$ -725.28K
Currency in USD

Trxade Group Earnings and Revenue History

Trxade Group Debt to Assets

Trxade Group Cash Flow

Trxade Group Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis